Literature DB >> 11684871

Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction.

J Dupont1, D LeRoith.   

Abstract

The insulin receptor (IR) and the insulin-like growth factor I receptor (IGF-IR) belong to the same subfamily of receptor tyrosine kinases with two extracellular alpha-subunits and two transmembrane beta-subunits. They share a high similarity of structure and intracellular signalling events. However, the IR and the IGF-IR mediate different effects on metabolism, cell proliferation, apoptosis and differentiation. Although some of the variation can be attributed to a different tissue distribution or subcellular localization, it can also be explained by structural differences in the beta-subunit, which may result in activation of specific substrates and signal pathways. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684871     DOI: 10.1159/000063469

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  58 in total

1.  Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.

Authors:  Xiaonan Hou; Fei Huang; Luciana F Macedo; Sean C Harrington; Karen A Reeves; Ann Greer; Friedrich Graf Finckenstein; Angela Brodie; Marco M Gottardis; Joan M Carboni; Paul Haluska
Journal:  Cancer Res       Date:  2011-10-31       Impact factor: 12.701

Review 2.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

3.  Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome.

Authors:  David R Weber; Diana E Stanescu; Robert Semple; Cheryl Holland; Sheela N Magge
Journal:  J Pediatr Endocrinol Metab       Date:  2014-11       Impact factor: 1.634

Review 4.  Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.

Authors:  Sripriya Raman; Adda Grimberg; Steven G Waguespack; Bradley S Miller; Charles A Sklar; Lillian R Meacham; Briana C Patterson
Journal:  J Clin Endocrinol Metab       Date:  2015-04-03       Impact factor: 5.958

Review 5.  Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.

Authors:  Pushpendra Singh; Jimi Marin Alex; Felix Bast
Journal:  Med Oncol       Date:  2013-12-14       Impact factor: 3.064

Review 6.  Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC).

Authors:  Johannes Loffing; Christoph Korbmacher
Journal:  Pflugers Arch       Date:  2009-03-11       Impact factor: 3.657

7.  Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans.

Authors:  Weinan Zhou; Blair M Rowitz; Megan J Dailey
Journal:  Exp Biol Med (Maywood)       Date:  2018-06-27

8.  Interactions between age, stress and insulin on cognition: implications for Alzheimer's disease.

Authors:  Maite Solas; Bárbara Aisa; María C Mugueta; Joaquín Del Río; Rosa M Tordera; María J Ramírez
Journal:  Neuropsychopharmacology       Date:  2010-02-24       Impact factor: 7.853

9.  Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.

Authors:  Elizabeth M Wilson; Jolana Tureckova; Peter Rotwein
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

10.  Synchronization in G0/G1 enhances the mitogenic response of cells overexpressing the human insulin receptor A isoform to insulin.

Authors:  Christine Bonnesen; Gitte-Mai Nelander; Bo Falck Hansen; Pia Jensen; Jonas S Krabbe; Marianne B Jensen; Anne Charlotte Hegelund; Jette E Svendsen; Martin B Oleksiewicz
Journal:  Cell Biol Toxicol       Date:  2009-11-08       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.